Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-076642
Filing Date
2025-08-14
Accepted
2025-08-14 16:06:35
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0252218-10q_china.htm   iXBRL 10-Q 565390
2 CERTIFICATION ea025221801ex31-1_china.htm EX-31.1 9953
3 CERTIFICATION ea025221801ex31-2_china.htm EX-31.2 9977
4 CERTIFICATION ea025221801ex32-1_china.htm EX-32.1 5357
  Complete submission text file 0001213900-25-076642.txt   4147932

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20250630.xsd EX-101.SCH 39140
6 XBRL CALCULATION FILE cphi-20250630_cal.xml EX-101.CAL 40587
7 XBRL DEFINITION FILE cphi-20250630_def.xml EX-101.DEF 187733
8 XBRL LABEL FILE cphi-20250630_lab.xml EX-101.LAB 344503
9 XBRL PRESENTATION FILE cphi-20250630_pre.xml EX-101.PRE 199972
69 EXTRACTED XBRL INSTANCE DOCUMENT ea0252218-10q_china_htm.xml XML 376054
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 251218857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)